IndraLab

Statements


USP9X activates JAK2. 2 / 2
| 2

reach
"USP9X positively regulated the JAK2 and STAT3 pathway to promote the malignant progression of liver cancer cells."

reach
"We further found that activated JAK2 may be naturally suppressed in 25% of CRLF2 pos DS-ALLs by loss-of-function aberrations in USP9X, a deubiquitinase previously shown to stabilize the activated phosphorylated JAK2."